LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | - | - | - |
What is the latest Contingent Liabilities ratio of LASA SUPERGENERICS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
| Mar2020 | - |
How is Contingent Liabilities of LASA SUPERGENERICS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | 0 | |
| Mar2020 | - | - | |
Compare Contingent Liabilities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹54.7 Cr | 19.6% | 10.5% | -56.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,121.0 Cr | 0.6% | -4.9% | -8.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,918.0 Cr | -1% | -1.7% | 5.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,960.0 Cr | 1.3% | 1.8% | 13.7% | Stock Analytics | |
| CIPLA | ₹122,725.0 Cr | 1.9% | -0.1% | -1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,224.0 Cr | -1.4% | -2.2% | -8.3% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | 19.6% |
10.5% |
-56.2% |
| SENSEX | 0.9% |
0.4% |
9.3% |
You may also like the below Video Courses